Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000376817 | SCV000483483 | uncertain significance | Retinal dystrophy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000284540 | SCV000483484 | uncertain significance | OTX2-Related Syndromic Microphthalmia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000346482 | SCV000483485 | uncertain significance | Combined Pituitary Hormone Deficiency, Dominant | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000400816 | SCV000483486 | uncertain significance | Syndromic Microphthalmia, Dominant | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003311797 | SCV004010287 | likely benign | not provided | 2023-05-01 | criteria provided, single submitter | clinical testing | OTX2: BS1 |
Breakthrough Genomics, |
RCV003311797 | SCV005191379 | uncertain significance | not provided | criteria provided, single submitter | not provided |